Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 1/20 | 0.62 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.51 |
| ▸ | TP53 | P04637 | 4/20 | 0.49 |
| ▸ | MAPT | P10636 | 5/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | GALR3 | O60755 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | NR2F2 | P24468 | 1/20 | 0.43 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6071885 | 0.85 | ALDH1A1 (0.45) | HPGDSMN1; SMN2TP53MAPTALDH1A1 | |
| SCHEMBL6071549 | 0.85 | SMN1; SMN2 (0.64) | HPGDSMN1; SMN2TP53MAPTALDH1A1 | |
| SCHEMBL4639498 | 0.84 | ALDH1A1 (0.44) | HPGDSMN1; SMN2TP53MAPTALDH1A1 | |
| SCHEMBL4637929 | 0.84 | HPGD (0.45) | HPGDSMN1; SMN2TP53MAPTALDH1A1 | |
| SCHEMBL5797687 | 0.81 | CASP1 (0.43) | HPGDSMN1; SMN2TP53ALDH1A1MEN1 | |
| SCHEMBL5797474 | 0.81 | ALDH1A1 (0.42) | HPGDSMN1; SMN2TP53MAPTALDH1A1 | |
| SCHEMBL5797506 | 0.81 | AKR1C3 (0.45) | HPGDSMN1; SMN2TP53MAPTALDH1A1 | |
| SCHEMBL5795924 | 0.80 | CASP1 (0.42) | HPGDSMN1; SMN2TP53ALDH1A1MEN1 | |
| SCHEMBL5796504 | 0.80 | ALDH1A1 (0.44) | HPGDSMN1; SMN2TP53MAPTALDH1A1 | |
| SCHEMBL4638473 | 0.80 | ALDH1A1 (0.65) | HPGDSMN1; SMN2ALDH1A1GAATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060160794-A1 | Tachykinin receptor antagonists | ELI LILLY AND COMPANY | 2006-07-20 | — | — | US | disclosed |
| EP-1638944-A1 | TACHYKININ RECEPTOR ANTAGONISTS | ELI LILLY AND COMPANY (US) | 2006-03-29 | — | — | EP | disclosed |
| WO-2005000821-A1 | TACHYKININ RECEPTOR ANTAGONISTS | ELI LILLY AND COMPANY (US) | 2005-01-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060160794-A1 | Tachykinin receptor antagonists | TACR1, TACR2, PROKR1 | HPGD 1291/4885SMN1; SMN2 2953/4885TP53 3863/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.